1. Гурьев Д.Л., Охапкин М.Б., Карпов Н.Ю., Блинов Д.В. Течение и исходы беременности, осложненной преэклампсией, в зависимости от типа центральной материнской гемодинамики // Акушерство и гинекология. 2011. (7-2). 14–19.
2. Титов В.Н., Дмитриев В.Ф., Гущина О.В. и др. Физико-химическая активность мочевой кислоты. Гиперурикемия – нарушение биологических функций эндоэкологии и адаптации, биологических реакций экскреции, воспаления и гидродинамического артериального давления // Успехи соврем. биол. 2011. 131. (5). 483–502.
3. Bellomo G. Serum uric acid and pre-eclampsia: an update // Expert Rev. Cardiovasc. Ther. 2012. 10. 701–705.
4. Bergamini C., Cicoira M., Rossi A., Vassanelli C. Oxidative stress and hyperuricaemia:pathophysiology,clinical relevance,and therapeutic implications in chronic heart failure // Eur. J. Heart Fail. 2009. 11. (5). 444–452.
5. Bruun J.M., Helge J.W., Richelsen B., Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects // Am. J. Physiol. Endocrinol. Metab. 2006. 290. (5). E961–E967.
6. Chambers J.C., Fusi L., Malik I.S. et al. Association of maternal endothelial disfunction with preeclampsia // J. Amer. Med. Assoc. 2001. 285. (12). 1607–1612.
7. Chang F.M., Chow S.N., Huang H.C. et al. The placental transfer and concentration difference in maternal and neonatal serum uric acid at parturition:comparison of normal pregnancies and gestosis // Biol. Res. Pregnan. Perinatol. 1987. 8. 35–39.
8. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant function of uric acid // Biochem. J. 1986. 235. (3). 747–754.
9. Duffy S.J., Biegelsen E.S., Holbrook M. et al. Iron chelation improves endothelial function in patients with coronary artery disease // Circulation. 2001. 103. 2799–2804.
10. Ghaemi-Oskouie F., Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation // Curr. Rheumatol. Rep. 2011. 13. (2). 160–166.
11. Han H.J., Lim M.J., Lee J.H. et al. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kB // Am. J. Physiol. Renal Physiol. 2007. 292. (1). F373–F381.
12. Johnson R.J., Feig D.I., Herrera-Acosta J., Kang D.H. Resurrection of uric acid as a causal risk factor in essential hypertension // Hypertension. 2005. 45. 18–20.
13. Li L., Frei B. Iron chelation inhibits NF-kB–mediated adhesion molecule expression by inhibiting p22 phox protein expression and NADPH oxidase activity // Arterioscler. Tromb. Vasc. Biol. 2006. 26. 2638–2643.
14. Martinon F. Detection of immune danger signals by NALP3 // J. Leukoc. Biol. 2008. 83. (3). 507–511.
15. Messerli F.H., Frochlich E.D., Dreslinski G.R. et al. Serum uric acid in essential hypertension:an indicator of renal vascular involvement // Ann. Intern. Med. 1980. 93. (6). 817–821.
16. Pennington K.A., Schlitt J.M., Jackson D.L. et al. Preeclampsia: multiple approaches for a multifactorial disease // Dis. Model. Mech. 2012. 5. (1). 9–18.
17. Yang Z., XiaohuaW., Lei J. et al. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells // Am. J. Physiol. Renal Physiol. 2010. 299. (2). F338–F346.
